Response evaluation of neoadjuvant therapy in MIBC: clinical trial-derived evidence to guide practice
{{output}}
Objectives: To review how response to neoadjuvant therapy (NAT) is assessed in clinical trials of muscle-invasive bladder cancer (MIBC), and to determine whether trial-derived evidence can inform response evaluation in contempora... ...
